Drug
CDSCO approves Zaynich antibiotic ahead of FDA approval
Zaynich is a broad-spectrum antibiotic indicated for bacterial infections including odontogenic abscesses; dosing follows standard adult regimens (e.g., 500 mg twice daily) pending local guidelines; approved by CDSCO on 27 May 2026; available in India; offers a new option for managing resistant oral pathogens.
Source: Biotecnika
18 Nov 2026 · DentalSync AI — global BDS career platform